SODIUM FERRIC GLUCONATE COMPLEX

SODIUM FERRIC GLUCONATE COMPLEX was reported 2174 times

SODIUM FERRIC GLUCONATE COMPLEX is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 APPENDICOLITH 260 0.6718
1 SLEEP DISORDER THERAPY 101 0.5101
2 ACCESSORY MUSCLE 3 0.5000
3 ANTACID THERAPY 52 0.4000
4 ANALGESIC THERAPY 102 0.3178
5 DRUG THERAPY 95 0.2802
6 DISSECTING CORONARY ARTERY ANEURYSM 1 0.2000
7 ANTICOAGULANT THERAPY 49 0.1725
8 BACTEROIDES INFECTION 38 0.1456
9 CONGENITAL HIATUS HERNIA 32 0.1404
10 MALIGNANT MELANOMA STAGE 0 27 0.1292
11 BENIGN DUODENAL NEOPLASM 1 0.0769
12 ARTERIOVENOUS FISTULA, ACQUIRED 1 0.0667
13 BLOOD PHOSPHORUS INCREASED 180 0.0659
14 HYPERPHOSPHATAEMIA 134 0.0623
15 SHUNT THROMBOSIS 5 0.0505
16 ARTERIOVENOUS FISTULA ANEURYSM 2 0.0488
17 ARTERIOVENOUS SHUNT OPERATION 2 0.0392
18 PROCTITIS HAEMORRHAGIC 3 0.0385
19 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 32 0.0345
20 ANORECTAL VARICES HAEMORRHAGE 1 0.0312
21 TOTAL LUNG CAPACITY DECREASED 48 0.0300
22 APPENDICITIS 263 0.0281
23 FISHBANE REACTION 2 0.0256
24 IRON DEFICIENCY 115 0.0255
25 BLOOD URIC ACID INCREASED 146 0.0253
26 SKIN FIBROSIS 11 0.0227
27 ANTI-ERYTHROPOIETIN ANTIBODY NEGATIVE 2 0.0220
28 MENINGITIS ENTEROVIRAL 2 0.0215
29 VENTRICULAR FIBRILLATION 231 0.0208
30 AORTIC STENOSIS 71 0.0204
31 COELIAC ARTERY OCCLUSION 1 0.0192
32 MYASTHENIA GRAVIS 153 0.0189
33 AMELOBLASTOMA 1 0.0189
34 HYPOPHOSPHATAEMIA 135 0.0182
35 CARDIOGENIC SHOCK 258 0.0180
36 CATHETER SITE GRANULOMA 1 0.0175
37 ULTRASOUND DOPPLER ABNORMAL 3 0.0173
38 CARDIAC VALVE THICKENING 1 0.0169
39 LUNG OPACITY 44 0.0167
40 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 77 0.0152
41 LICE INFESTATION 3 0.0143
42 NEPHROGENIC SYSTEMIC FIBROSIS 42 0.0139
43 CSF WHITE BLOOD CELL COUNT POSITIVE 1 0.0135
44 EPIDERMOLYSIS 6 0.0130
45 ARTERIOSCLEROSIS OBLITERANS 1 0.0123
46 SHUNT OCCLUSION 6 0.0118
47 EXTREMITY CONTRACTURE 7 0.0109
48 SCLEROSING ENCAPSULATING PERITONITIS 2 0.0109
49 CONNECTIVE TISSUE INFLAMMATION 1 0.0105
50 CSF GLUCOSE INCREASED 1 0.0104
51 JOINT CONTRACTURE 11 0.0103
52 SKIN INDURATION 21 0.0101
53 DIALYSIS HYPOTENSION 1 0.0101
54 PLEURITIC PAIN 26 0.0094
55 MULTIPLE ORGAN DYSFUNCTION SYNDROME 265 0.0093
56 ASCITES 267 0.0091
57 TROPONIN INCREASED 65 0.0085
58 JEJUNAL PERFORATION 2 0.0083
59 CONTRAST MEDIA TOXICITY 1 0.0079
60 BACTERIAL INFECTION 147 0.0079
61 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 133 0.0078
62 BRIEF RESOLVED UNEXPLAINED EVENT 1 0.0076
63 SKIN HYPERTROPHY 21 0.0075
64 ABDOMINAL WALL INFECTION 1 0.0075
65 INFUSION SITE URTICARIA 5 0.0075
66 APPLICATION SITE NODULE 1 0.0073
67 ATOPY 2 0.0072
68 OESOPHAGITIS HAEMORRHAGIC 2 0.0071
69 RESPIRATORY SYMPTOM 20 0.0070
70 CYTOTOXIC LESIONS OF CORPUS CALLOSUM 1 0.0068
71 BLOOD PRESSURE ORTHOSTATIC ABNORMAL 1 0.0065
72 BACTERIAL TRANSLOCATION 2 0.0063
73 BLOOD CALCIUM INCREASED 55 0.0063
74 INJECTION SITE THROMBOSIS 2 0.0061
75 NEURALGIA 144 0.0059
76 CERVICAL INCOMPETENCE 3 0.0059
77 APPLICATION SITE INDURATION 1 0.0059
78 PULSE PRESSURE DECREASED 3 0.0059
79 ANAL INJURY 1 0.0058
80 EYE ROLLING 4 0.0056
81 BLOOD COPPER INCREASED 1 0.0056
82 HYPERLIPIDAEMIA 67 0.0056
83 BRAIN STEM ISCHAEMIA 1 0.0056
84 CHRONIC LEFT VENTRICULAR FAILURE 2 0.0056
85 BREATH SOUNDS ABNORMAL 27 0.0055
86 BENIGN PROSTATIC HYPERPLASIA 27 0.0052
87 BREAST OEDEMA 1 0.0052
88 ENCOPRESIS 1 0.0052
89 ADMINISTRATION RELATED REACTION 1 0.0051
90 SKIN TIGHTNESS 24 0.0051
91 BRAIN TUMOUR OPERATION 1 0.0050
92 PLASMA CELL LEUKAEMIA 3 0.0050
93 LICHENIFICATION 2 0.0049
94 FAECAL INCONTINENCE 23 0.0048
95 END STAGE RENAL DISEASE 87 0.0048
96 HYPONATRAEMIA 268 0.0048
97 ULCER 75 0.0047
98 BLOOD PRESSURE IMMEASURABLE 7 0.0046
99 ACID BASE BALANCE ABNORMAL 1 0.0045
100 POST INFLAMMATORY PIGMENTATION CHANGE 2 0.0044
101 AIR EMBOLISM 2 0.0042
102 GOUT 75 0.0042
103 EXTRAVASATION 17 0.0041
104 ASPARTATE AMINOTRANSFERASE 1 0.0041
105 DIABETIC VASCULAR DISORDER 1 0.0040
106 ANTI-ERYTHROPOIETIN ANTIBODY POSITIVE 1 0.0040
107 STEROID WITHDRAWAL SYNDROME 4 0.0039
108 NO REACTION ON PREVIOUS EXPOSURE TO DRUG 2 0.0038
109 ARTERIOVENOUS FISTULA OPERATION 1 0.0037
110 BLOOD TEST ABNORMAL 52 0.0037
111 COOMBS TEST POSITIVE 1 0.0037
112 INFUSION SITE RASH 5 0.0036
113 ANAPHYLACTOID REACTION 15 0.0036
114 DERMAL ABSORPTION IMPAIRED 1 0.0036
115 CATHETER SITE INFLAMMATION 2 0.0036
116 DIABETIC GANGRENE 1 0.0035
117 RALES 20 0.0034
118 HYPERBILIRUBINAEMIA NEONATAL 2 0.0034
119 AORTIC CALCIFICATION 2 0.0034
120 BLOOD CHOLESTEROL INCREASED 152 0.0033
121 FIBROSIS 10 0.0032
122 PRESSURE OF SPEECH 2 0.0031
123 BLOOD PRESSURE SYSTOLIC DECREASED 14 0.0031
124 INFUSION RELATED REACTION 200 0.0030
125 ASPIRATION 33 0.0030
126 COMPLICATIONS OF MATERNAL EXPOSURE TO THERAPEUTIC DRUGS 2 0.0029
127 DIAPHRAGMALGIA 1 0.0029
128 LIVEDO RETICULARIS 6 0.0029
129 INFUSION SITE DISCHARGE 5 0.0028
130 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 3 0.0028
131 CORONARY ARTERY INSUFFICIENCY 1 0.0028
132 ANGIODYSPLASIA 1 0.0027
133 ECLAMPSIA 1 0.0027
134 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 141 0.0027
135 SEPSIS 301 0.0027
136 BRONCHIECTASIS 18 0.0027
137 KLEBSIELLA SEPSIS 3 0.0027
138 ABDOMINAL DISTENSION 278 0.0027
139 INTENTIONAL MISUSE 5 0.0026
140 NEPHROGENIC ANAEMIA 12 0.0026
141 CEREBELLAR STROKE 1 0.0026
142 GENERAL PHYSICAL HEALTH DETERIORATION 293 0.0025
143 STREPTOCOCCAL SEPSIS 3 0.0025
144 IRON DEFICIENCY ANAEMIA 23 0.0025
145 ELECTROCARDIOGRAM T WAVE PEAKED 1 0.0025
146 MICTURITION URGENCY 28 0.0024
147 BRADYCARDIA FOETAL 2 0.0024
148 HYPERCHOLESTEROLAEMIA 23 0.0024
149 LIP DISCOLOURATION 3 0.0024
150 MICROCEPHALY 3 0.0023
151 VITAL FUNCTIONS ABNORMAL 2 0.0023
152 DRY MOUTH 182 0.0022
153 CIRRHOSIS ALCOHOLIC 1 0.0022
154 ANASTOMOTIC ULCER 1 0.0022
155 FULL BLOOD COUNT ABNORMAL 23 0.0022
156 CEREBRAL HYPOPERFUSION 1 0.0021
157 ANAPHYLACTOID SHOCK 1 0.0021
158 PAINFUL RESPIRATION 5 0.0021
159 SWELLING 192 0.0020
160 OROPHARYNGEAL SWELLING 2 0.0020
161 ANAEMIA VITAMIN B12 DEFICIENCY 1 0.0020
162 LYMPHOCYTIC INFILTRATION 2 0.0020
163 COMPLICATIONS OF TRANSPLANT SURGERY 1 0.0020
164 AORTIC VALVE CALCIFICATION 1 0.0019
165 UTERINE CONTRACTIONS DURING PREGNANCY 2 0.0019
166 DIABETES MELLITUS 147 0.0019
167 PULSE ABSENT 9 0.0019
168 THROMBOSIS 148 0.0018
169 KIDNEY ENLARGEMENT 2 0.0018
170 SLEEP DISORDER 129 0.0018
171 RESUSCITATION 3 0.0018
172 ANAPHYLACTIC REACTION 99 0.0018
173 ABDOMINAL PAIN 415 0.0018
174 LIVER FUNCTION TEST INCREASED 38 0.0018
175 BURNOUT SYNDROME 1 0.0018
176 ENANTHEMA 1 0.0017
177 ANTIPHOSPHOLIPID ANTIBODIES POSITIVE 1 0.0017
178 OBSTRUCTIVE AIRWAYS DISORDER 19 0.0017
179 SPUTUM DISCOLOURED 16 0.0017
180 ARTERIOVENOUS FISTULA SITE COMPLICATION 1 0.0017
181 INTENTIONAL PRODUCT MISUSE 145 0.0017
182 MALIGNANT MELANOMA IN SITU 2 0.0016
183 HYPERPARATHYROIDISM SECONDARY 4 0.0016
184 TOXIC EPIDERMAL NECROLYSIS 24 0.0016
185 SLOW RESPONSE TO STIMULI 2 0.0015
186 TONIC CLONIC MOVEMENTS 2 0.0015
187 PULMONARY EMBOLISM 144 0.0015
188 JOINT RANGE OF MOTION DECREASED 20 0.0015
189 DRUG INTOLERANCE 144 0.0015
190 ACUTE LEFT VENTRICULAR FAILURE 1 0.0015
191 WOUND DEHISCENCE 5 0.0015
192 ISCHAEMIC HEPATITIS 2 0.0015
193 APLASIA PURE RED CELL 5 0.0015
194 BLOOD PRESSURE DECREASED 96 0.0014
195 LOGORRHOEA 5 0.0014
196 DELAYED GRAFT FUNCTION 1 0.0014
197 PELVIC VENOUS THROMBOSIS 2 0.0014
198 HEART VALVE INCOMPETENCE 4 0.0014
199 CARDIAC ENZYMES INCREASED 1 0.0014
200 BLOOD PARATHYROID HORMONE INCREASED 4 0.0014
201 ACUTE ABDOMEN 2 0.0014
202 AMPHETAMINES POSITIVE 1 0.0013
203 ADHESION 2 0.0013
204 CARBOHYDRATE ANTIGEN 15-3 INCREASED 1 0.0013
205 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 5 0.0013
206 LOWER RESPIRATORY TRACT INFECTION 59 0.0013
207 HAEMOLYTIC URAEMIC SYNDROME 3 0.0013
208 FLANK PAIN 12 0.0013
209 ENDOCARDITIS BACTERIAL 1 0.0013
210 BRONCHIAL CARCINOMA 1 0.0013
211 ELECTROMECHANICAL DISSOCIATION 1 0.0013
212 STARING 3 0.0012
213 COLON CANCER METASTATIC 2 0.0012
214 ABDOMINAL SYMPTOM 1 0.0012
215 RESPIRATORY DISORDER NEONATAL 2 0.0012
216 DOCUMENTED HYPERSENSITIVITY TO ADMINISTERED PRODUCT 1 0.0012
217 JOINT INJURY 26 0.0012
218 TRANSAMINASES INCREASED 27 0.0012
219 CSF PROTEIN INCREASED 1 0.0012
220 SPINAL DEFORMITY 2 0.0012
221 CONSTIPATION 259 0.0012
222 CONGENITAL CYSTIC KIDNEY DISEASE 1 0.0012
223 PARAESTHESIA ORAL 17 0.0012
224 BRONCHOPNEUMONIA 4 0.0012
225 SERUM FERRITIN DECREASED 2 0.0012
226 OEDEMA PERIPHERAL 139 0.0011
227 ANGIONEUROTIC OEDEMA 3 0.0011
228 STEVENS-JOHNSON SYNDROME 25 0.0011
229 AORTIC VALVE STENOSIS 2 0.0011
230 CANDIDA SEPSIS 1 0.0011
231 LARYNGOSPASM 3 0.0011
232 PALLOR 30 0.0011
233 HYPERKERATOSIS 6 0.0011
234 PULMONARY MASS 16 0.0011
235 MUSCULOSKELETAL STIFFNESS 94 0.0011
236 LUNG CONSOLIDATION 3 0.0011
237 SKIN PLAQUE 9 0.0011
238 URTICARIA 176 0.0010
239 HYPOTENSION 210 0.0010
240 PULMONARY FIBROSIS 20 0.0010
241 HYPERVENTILATION 6 0.0010
242 ANAL CANCER 1 0.0010
243 SKIN WARM 6 0.0010
244 SENSATION OF HEAVINESS 4 0.0010
245 CONVERSION DISORDER 2 0.0010
246 JOINT STIFFNESS 27 0.0010
247 ANAEMIA 196 0.0010
248 BONE MARROW DEPRESSION 1 0.0010
249 CORONARY ARTERY DISEASE 31 0.0010
250 PLEURAL EFFUSION 62 0.0010
251 OCCULT BLOOD POSITIVE 2 0.0010
252 DIPLEGIA 2 0.0010
253 ADMINISTRATION SITE EXTRAVASATION 1 0.0010
254 DEVICE RELATED SEPSIS 2 0.0010
255 CATHETER RELATED INFECTION 1 0.0010
256 MUSCLE CONTRACTURE 2 0.0010
257 VOMITING 463 0.0010
258 SOMNOLENCE 197 0.0010
259 CACHEXIA 5 0.0010
260 DERMATITIS BULLOUS 7 0.0010
261 INFUSION SITE EXTRAVASATION 6 0.0010
262 MICROCYTIC ANAEMIA 2 0.0010
263 CARPAL TUNNEL DECOMPRESSION 1 0.0009
264 INFUSION SITE ERYTHEMA 8 0.0009
265 SERUM FERRITIN INCREASED 5 0.0009
266 CHEST DISCOMFORT 97 0.0009
267 BLOOD SODIUM ABNORMAL 1 0.0009
268 ASPARTATE AMINOTRANSFERASE INCREASED 50 0.0009
269 BLOOD CREATININE INCREASED 61 0.0009
270 UNRESPONSIVE TO STIMULI 24 0.0009
271 SWOLLEN TONGUE 29 0.0009
272 HYPOVENTILATION 3 0.0009
273 THROMBOSIS IN DEVICE 3 0.0009
274 ACINETOBACTER INFECTION 1 0.0009
275 COLD SWEAT 16 0.0009
276 CARDIOVASCULAR DISORDER 23 0.0009
277 HYPOTONIA 9 0.0009
278 AORTIC DILATATION 1 0.0009
279 TONGUE BLISTERING 2 0.0009
280 COLITIS ISCHAEMIC 6 0.0009
281 CATHETER RELATED COMPLICATION 1 0.0009
282 BURNING SENSATION 62 0.0009
283 SUDDEN CARDIAC DEATH 3 0.0009
284 BREAKTHROUGH PAIN 2 0.0009
285 HAEMOPTYSIS 24 0.0009
286 DILATATION ATRIAL 1 0.0009
287 PULMONARY INFARCTION 2 0.0008
288 LIP SWELLING 28 0.0008
289 OXYGEN CONSUMPTION INCREASED 2 0.0008
290 ENTEROCOCCAL INFECTION 4 0.0008
291 HYPERHIDROSIS 106 0.0008
292 EJECTION FRACTION ABNORMAL 1 0.0008
293 EYE OEDEMA 2 0.0008
294 SKIN HYPERPIGMENTATION 7 0.0008
295 LARYNGEAL OEDEMA 5 0.0008
296 ACUTE PSYCHOSIS 2 0.0008
297 BLADDER DISCOMFORT 1 0.0008
298 TRANSIENT ISCHAEMIC ATTACK 27 0.0008
299 HYPOXIA 28 0.0008
300 INFUSION SITE SWELLING 5 0.0008
301 APPLICATION SITE WARMTH 1 0.0008
302 COMMUNICATION DISORDER 3 0.0008
303 HAEMOLYSIS 6 0.0008
304 ADJUSTMENT DISORDER 1 0.0008
305 HEART RATE DECREASED 27 0.0008
306 CARDIOACTIVE DRUG LEVEL INCREASED 1 0.0008
307 BLOOD IRON DECREASED 9 0.0008
308 GRAND MAL CONVULSION 7 0.0008
309 CYSTITIS NONINFECTIVE 1 0.0007
310 THROAT TIGHTNESS 20 0.0007
311 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 3 0.0007
312 BEZOAR 1 0.0007
313 HYPERPYREXIA 3 0.0007
314 PREMATURE LABOUR 4 0.0007
315 AORTIC VALVE INCOMPETENCE 3 0.0007
316 INCORRECT DRUG ADMINISTRATION RATE 3 0.0007
317 JOINT LOCK 2 0.0007
318 DYSPNOEA 397 0.0007
319 BLADDER TRANSITIONAL CELL CARCINOMA 1 0.0007
320 PHARYNGEAL DISORDER 2 0.0007
321 PARAESTHESIA 109 0.0007
322 AUTONOMIC NERVOUS SYSTEM IMBALANCE 2 0.0007
323 HAEMORRHAGIC ANAEMIA 3 0.0007
324 CARDIAC FIBRILLATION 1 0.0007
325 DARK CIRCLES UNDER EYES 1 0.0007
326 SYNCOPE 68 0.0007
327 ENTEROCOLITIS HAEMORRHAGIC 1 0.0007
328 RESPIRATORY RATE INCREASED 6 0.0007
329 BLOOD PARATHYROID HORMONE DECREASED 1 0.0007
330 CONDITION AGGRAVATED 205 0.0007
331 UPPER RESPIRATORY TRACT INFECTION 31 0.0007
332 METABOLIC ENCEPHALOPATHY 2 0.0007
333 HYPERCAPNIA 2 0.0007
334 VASCULAR DEVICE INFECTION 3 0.0007
335 PRESYNCOPE 16 0.0007
336 NAUSEA 519 0.0007
337 DYSAESTHESIA 2 0.0007
338 CHEST X-RAY ABNORMAL 2 0.0007
339 RENAL FAILURE CHRONIC 5 0.0006
340 URINARY INCONTINENCE 19 0.0006
341 INJECTION SITE DISCOLOURATION 8 0.0006
342 HYPERTENSIVE CRISIS 7 0.0006
343 MUSCLE TIGHTNESS 10 0.0006
344 PERIPHERAL SWELLING 95 0.0006
345 LIVER ABSCESS 2 0.0006
346 CARDIOVASCULAR INSUFFICIENCY 1 0.0006
347 BACTERIAL SEPSIS 2 0.0006
348 TACHYCARDIA 54 0.0006
349 HYPERVOLAEMIA 3 0.0006
350 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 2 0.0006
351 SMALL FOR DATES BABY 3 0.0006
352 POST PROCEDURAL HAEMORRHAGE 7 0.0006
353 ARTHROPOD STING 1 0.0006
354 DERMATITIS EXFOLIATIVE 3 0.0006
355 HAEMODIALYSIS 5 0.0006
356 ENTEROBACTER INFECTION 1 0.0006
357 KLEBSIELLA INFECTION 3 0.0006
358 MOTOR DYSFUNCTION 6 0.0006
359 CHEST PAIN 109 0.0006
360 CIRCULATORY COLLAPSE 10 0.0006
361 ANAPHYLACTIC SHOCK 15 0.0006
362 PRIAPISM 2 0.0006
363 BLOOD CHLORIDE INCREASED 1 0.0006
364 SKIN NECROSIS 3 0.0006
365 PERIORBITAL OEDEMA 3 0.0006
366 MICTURITION DISORDER 2 0.0006
367 HYPOPNOEA 2 0.0006
368 CAROTID ARTERY STENOSIS 2 0.0006
369 CYANOSIS 9 0.0006
370 THROMBOPHLEBITIS 2 0.0006
371 BLOOD LACTIC ACID INCREASED 3 0.0006
372 MUSCLE CONTRACTIONS INVOLUNTARY 2 0.0006
373 BRADYCARDIA 30 0.0006
374 BACK PAIN 131 0.0006
375 SKIN WEEPING 2 0.0006
376 FACIAL BONES FRACTURE 2 0.0006
377 FLUSHING 56 0.0006
378 CALCIPHYLAXIS 1 0.0005
379 INTESTINAL ISCHAEMIA 3 0.0005
380 CHOKING SENSATION 3 0.0005
381 NECROSIS 3 0.0005
382 DEFORMITY 5 0.0005
383 BLOOD IRON INCREASED 1 0.0005
384 CATHETER SITE INFECTION 2 0.0005
385 BLOOD BICARBONATE DECREASED 1 0.0005
386 PERONEAL NERVE PALSY 3 0.0005
387 SCAR 9 0.0005
388 CARDIOPULMONARY FAILURE 2 0.0005
389 HYPOVOLAEMIA 3 0.0005
390 PERIPHERAL COLDNESS 7 0.0005
391 LOSS OF CONSCIOUSNESS 65 0.0005
392 RESPIRATORY DISTRESS 14 0.0005
393 EMPYEMA 1 0.0005
394 OESOPHAGEAL CANDIDIASIS 2 0.0005
395 AZOTAEMIA 2 0.0005
396 CARDIAC DISCOMFORT 1 0.0005
397 ANHEDONIA 13 0.0005
398 FOETAL GROWTH RESTRICTION 3 0.0005
399 ARTHRITIS BACTERIAL 2 0.0005
400 CHOLANGITIS SCLEROSING 1 0.0005
401 DIVERTICULAR PERFORATION 1 0.0005
402 ACUTE CORONARY SYNDROME 4 0.0005
403 AKINESIA 1 0.0005
404 DEVICE CONNECTION ISSUE 1 0.0005
405 HYPERTENSION 100 0.0005
406 LUNG DISORDER 23 0.0005
407 THROAT IRRITATION 21 0.0005
408 HYPOAESTHESIA ORAL 7 0.0005
409 BLOOD PRESSURE SYSTOLIC INCREASED 9 0.0005
410 OCULAR ICTERUS 2 0.0005
411 SKIN SWELLING 4 0.0005
412 REFUSAL OF TREATMENT BY PATIENT 3 0.0005
413 CERVICAL DYSPLASIA 1 0.0005
414 DIVERTICULUM INTESTINAL 2 0.0005
415 BIPOLAR I DISORDER 1 0.0005
416 ENDOMETRIAL CANCER 1 0.0005
417 DIABETIC NEPHROPATHY 1 0.0005
418 ARTERIOSCLEROSIS CORONARY ARTERY 3 0.0005
419 ELECTROCARDIOGRAM T WAVE INVERSION 1 0.0005
420 CATHETERISATION CARDIAC 2 0.0005
421 EXPOSURE DURING PREGNANCY 28 0.0005
422 CARDIAC FAILURE ACUTE 3 0.0004
423 SKIN MASS 3 0.0004
424 BACTERIAL TEST POSITIVE 1 0.0004
425 ANAL INCONTINENCE 4 0.0004
426 SUSPECTED OFF LABEL USE 2 0.0004
427 BLOOD LOSS ANAEMIA 1 0.0004
428 COMPLICATIONS OF TRANSPLANTED KIDNEY 1 0.0004
429 HYPOAESTHESIA 66 0.0004
430 ABDOMINAL HERNIA 2 0.0004
431 SKIN DISCOLOURATION 20 0.0004
432 DROOLING 3 0.0004
433 PERICARDIAL EFFUSION 10 0.0004
434 BLOOD POTASSIUM INCREASED 7 0.0004
435 RENAL FUNCTION TEST ABNORMAL 2 0.0004
436 SWELLING FACE 28 0.0004
437 EXTRASYSTOLES 3 0.0004
438 MULTIPLE MYELOMA 2 0.0004
439 LIVER DISORDER 19 0.0004
440 DEFAECATION URGENCY 3 0.0004
441 DIALYSIS 6 0.0004
442 COAGULOPATHY 7 0.0004
443 KIDNEY TRANSPLANT REJECTION 2 0.0004
444 FACE OEDEMA 7 0.0004
445 HUMERUS FRACTURE 2 0.0004
446 HYPOKINESIA 6 0.0004
447 BLOOD IMMUNOGLOBULIN E INCREASED 1 0.0004
448 BRONCHITIS CHRONIC 1 0.0004
449 RENAL CELL CARCINOMA 2 0.0004
450 PHARYNGEAL SWELLING 4 0.0004
451 PRODUCT USE IN UNAPPROVED INDICATION 101 0.0004
452 CARDIOMEGALY 5 0.0004
453 DENTAL OPERATION 1 0.0004
454 INJECTION SITE EXTRAVASATION 5 0.0004
455 STAPHYLOCOCCAL SEPSIS 2 0.0004
456 INFLAMMATORY MARKER INCREASED 2 0.0004
457 ILEUS 5 0.0004
458 PROTEIN URINE PRESENT 2 0.0004
459 CATHETER SITE HAEMORRHAGE 1 0.0004
460 ERYSIPELAS 2 0.0004
461 CORONARY ARTERY STENOSIS 2 0.0004
462 HYPOTHERMIA 4 0.0004
463 HYPERTHERMIA 3 0.0004
464 ACIDOSIS 3 0.0004
465 FEELING HOT 24 0.0004
466 CANCER PAIN 1 0.0004
467 PHARYNGEAL OEDEMA 6 0.0004
468 ENDOCARDITIS 2 0.0004
469 CEREBRAL ISCHAEMIA 2 0.0004
470 BLOOD CHLORIDE DECREASED 1 0.0004
471 STOMACH DISCOMFORT 2 0.0004
472 HIATUS HERNIA 5 0.0004
473 FAILURE TO THRIVE 2 0.0004
474 COMPARTMENT SYNDROME 1 0.0004
475 POLYARTHRITIS 2 0.0004
476 INCONTINENCE 4 0.0004
477 SUDDEN DEATH 4 0.0004
478 RENAL PAIN 4 0.0004
479 CLOSTRIDIUM DIFFICILE COLITIS 4 0.0004
480 RETCHING 8 0.0004
481 AREFLEXIA 1 0.0004
482 MIOSIS 3 0.0004
483 ACUTE MYOCARDIAL INFARCTION 11 0.0004
484 SENSORY LOSS 3 0.0004
485 ANAL ABSCESS 2 0.0004
486 BLOOD SODIUM INCREASED 1 0.0004
487 TACHYPNOEA 5 0.0004
488 HYPERAESTHESIA 3 0.0004
489 FAECALOMA 2 0.0004
490 MALNUTRITION 4 0.0004
491 DIABETIC COMA 1 0.0004
492 ANAL HAEMORRHAGE 1 0.0004
493 ENDOTRACHEAL INTUBATION 1 0.0004
494 JOINT SWELLING 43 0.0004
495 LIMB DISCOMFORT 11 0.0004
496 HAEMATOCRIT DECREASED 7 0.0004
497 SHOCK 8 0.0003
498 PSYCHOLOGICAL TRAUMA 3 0.0003
499 SKIN ATROPHY 2 0.0003
500 DYSPNOEA AT REST 1 0.0003
501 LOCAL SWELLING 6 0.0003
502 CHOLECYSTITIS 4 0.0003
503 GASTROINTESTINAL DISORDER 30 0.0003
504 BLOOD CULTURE POSITIVE 1 0.0003
505 HYPERSENSITIVITY 62 0.0003
506 EMERGENCY CARE 1 0.0003
507 DIABETIC FOOT 1 0.0003
508 RESPIRATORY ARREST 9 0.0003
509 HYPOKALAEMIA 15 0.0003
510 BRAIN NATRIURETIC PEPTIDE INCREASED 1 0.0003
511 PIGMENTATION DISORDER 2 0.0003
512 PRURITUS GENERALISED 7 0.0003
513 GENERALISED OEDEMA 4 0.0003
514 GASTROOESOPHAGEAL REFLUX DISEASE 26 0.0003
515 DIARRHOEA HAEMORRHAGIC 3 0.0003
516 WHEEZING 19 0.0003
517 SWELLING OF EYELID 2 0.0003
518 MELAENA 7 0.0003
519 OFF LABEL USE 277 0.0003
520 CHILLS 37 0.0003
521 RASH MACULAR 11 0.0003
522 BILE DUCT STONE 1 0.0003
523 HYPERKALAEMIA 11 0.0003
524 HEART RATE INCREASED 31 0.0003
525 CARDIO-RESPIRATORY ARREST 13 0.0003
526 ATELECTASIS 3 0.0003
527 INFUSION SITE PAIN 4 0.0003
528 SINUS BRADYCARDIA 3 0.0003
529 ANTINUCLEAR ANTIBODY POSITIVE 1 0.0003
530 TENDON DISORDER 2 0.0003
531 HYPOGAMMAGLOBULINAEMIA 2 0.0003
532 VENTRICULAR TACHYCARDIA 5 0.0003
533 ERYTHEMA 62 0.0003
534 PSYCHOMOTOR HYPERACTIVITY 5 0.0003
535 ABDOMINAL PAIN UPPER 62 0.0003
536 ASTHMA 34 0.0003
537 MENINGITIS 2 0.0003
538 ATRIOVENTRICULAR BLOCK COMPLETE 2 0.0003
539 BLOOD UREA INCREASED 5 0.0003
540 EMPHYSEMA 3 0.0003
541 PRURITUS 114 0.0003
542 EYE SWELLING 11 0.0003
543 ARRHYTHMIA 14 0.0003
544 CLOSTRIDIAL INFECTION 1 0.0003
545 LETHARGY 17 0.0003
546 TREMOR 49 0.0003
547 MOBILITY DECREASED 21 0.0003
548 EYE MOVEMENT DISORDER 2 0.0003
549 ECCHYMOSIS 2 0.0003
550 ONYCHOCLASIS 2 0.0003
551 JOINT EFFUSION 2 0.0003
552 MULTI-ORGAN FAILURE 5 0.0003
553 LARGE INTESTINE POLYP 2 0.0003
554 MENTAL STATUS CHANGES 8 0.0003
555 FEELING COLD 8 0.0003
556 INJECTION SITE DISCOMFORT 3 0.0003
557 OXYGEN SATURATION DECREASED 16 0.0003
558 PAPULE 2 0.0003
559 ABASIA 7 0.0003
560 ASTHENIA 106 0.0003
561 METABOLIC ACIDOSIS 9 0.0003
562 APPENDICECTOMY 1 0.0003
563 GRAFT VERSUS HOST DISEASE 2 0.0003
564 APPARENT DEATH 1 0.0003
565 TONGUE DISORDER 2 0.0003
566 DEVICE KINK 1 0.0003
567 CAROTID ARTERY OCCLUSION 1 0.0003
568 DYSSTASIA 8 0.0003
569 WOUND INFECTION 3 0.0003
570 INJURY 19 0.0003
571 SKIN DISORDER 9 0.0003
572 DIZZINESS 134 0.0003
573 RASH PAPULAR 6 0.0003
574 BLOOD CALCIUM DECREASED 3 0.0003
575 TUBULOINTERSTITIAL NEPHRITIS 5 0.0003
576 GASTRITIS 7 0.0003
577 MITRAL VALVE INCOMPETENCE 3 0.0003
578 DRUG EXPOSURE DURING PREGNANCY 9 0.0003
579 HAEMODYNAMIC INSTABILITY 2 0.0003
580 CONVULSION 15 0.0003
581 MATERNAL DRUGS AFFECTING FOETUS 2 0.0003
582 ATRIOVENTRICULAR BLOCK 2 0.0003
583 BRONCHOPULMONARY ASPERGILLOSIS 2 0.0003
584 CAESAREAN SECTION 3 0.0003
585 SPLENOMEGALY 3 0.0003
586 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 46 0.0003
587 ELECTROCARDIOGRAM ABNORMAL 2 0.0003
588 DISORIENTATION 10 0.0003
589 BLOOD ALBUMIN DECREASED 2 0.0003
590 CEREBRAL ATROPHY 1 0.0003
591 PRESCRIBED UNDERDOSE 5 0.0003
592 RESPIRATORY FAILURE 18 0.0002
593 NO THERAPEUTIC RESPONSE 3 0.0002
594 DISCOMFORT 15 0.0002
595 DECUBITUS ULCER 2 0.0002
596 HAEMOGLOBIN DECREASED 25 0.0002
597 HYPERCALCAEMIA 3 0.0002
598 HAIR DISORDER 2 0.0002
599 PAIN IN EXTREMITY 71 0.0002
600 ATRIAL SEPTAL DEFECT 2 0.0002
601 PERICARDITIS 4 0.0002
602 UPPER GASTROINTESTINAL HAEMORRHAGE 4 0.0002
603 RENAL FAILURE ACUTE 10 0.0002
604 PSEUDOMONAS INFECTION 2 0.0002
605 ANOREXIA 3 0.0002
606 RECTAL HAEMORRHAGE 10 0.0002
607 SKIN ULCER 6 0.0002
608 BLOOD MAGNESIUM DECREASED 2 0.0002
609 THERAPEUTIC RESPONSE DECREASED 14 0.0002
610 ATRIOVENTRICULAR BLOCK FIRST DEGREE 1 0.0002
611 CARDIAC ARREST 19 0.0002
612 URINE OUTPUT DECREASED 2 0.0002
613 MUSCULAR WEAKNESS 26 0.0002
614 ABDOMINAL ABSCESS 1 0.0002
615 ANGIOEDEMA 10 0.0002
616 PURPURA 2 0.0002
617 BLOOD CREATINE INCREASED 1 0.0002
618 WRONG DRUG ADMINISTERED 2 0.0002
619 HAIR TEXTURE ABNORMAL 3 0.0002
620 FACIAL PAIN 2 0.0002
621 SINUS CONGESTION 3 0.0002
622 LEUKOCYTOSIS 4 0.0002
623 EAR DISORDER 1 0.0002
624 MOVEMENT DISORDER 7 0.0002
625 PNEUMONIA BACTERIAL 2 0.0002
626 BUNDLE BRANCH BLOCK RIGHT 1 0.0002
627 UROSEPSIS 2 0.0002
628 ERYTHEMA MULTIFORME 2 0.0002
629 ARTERIOSCLEROSIS 2 0.0002
630 PAIN IN JAW 6 0.0002
631 SINUS TACHYCARDIA 3 0.0002
632 CARDIAC TAMPONADE 1 0.0002
633 PARALYSIS 3 0.0002
634 ARTHRALGIA 87 0.0002
635 APHAGIA 1 0.0002
636 DIZZINESS POSTURAL 2 0.0002
637 THROMBOTIC MICROANGIOPATHY 2 0.0002
638 RENAL TUBULAR NECROSIS 2 0.0002
639 OEDEMA 11 0.0002
640 PULMONARY OEDEMA 9 0.0002
641 PNEUMONIA 65 0.0002
642 APPLICATION SITE SWELLING 1 0.0002
643 PREGNANCY 4 0.0002
644 HAEMATOCHEZIA 11 0.0002
645 PERITONITIS BACTERIAL 2 0.0002
646 ABDOMINAL PAIN LOWER 5 0.0002
647 CHRONIC KIDNEY DISEASE 15 0.0002
648 DRY THROAT 2 0.0002
649 PAIN 119 0.0002
650 POOR VENOUS ACCESS 2 0.0002
651 PERITONITIS 4 0.0002
652 VENTRICULAR EXTRASYSTOLES 2 0.0002
653 RESTLESSNESS 7 0.0002
654 PNEUMOTHORAX 3 0.0002
655 PREMATURE DELIVERY 3 0.0002
656 DIARRHOEA 121 0.0002
657 ANAL FISTULA 1 0.0002
658 CARDIAC FAILURE 15 0.0002
659 DECREASED ACTIVITY 2 0.0002
660 MUSCLE SPASMS 34 0.0002
661 DEEP VEIN THROMBOSIS 12 0.0002
662 FAECES DISCOLOURED 4 0.0002
663 INJECTION SITE SWELLING 14 0.0002
664 SKIN LESION 5 0.0002
665 GASTROINTESTINAL PAIN 2 0.0002
666 MEDICATION ERROR 10 0.0002
667 ANXIETY 51 0.0002
668 RASH 78 0.0002
669 THROMBOCYTOPENIA 20 0.0002
670 ANGIOPATHY 1 0.0002
671 SKIN EXFOLIATION 15 0.0002
672 CHOLECYSTITIS ACUTE 1 0.0002
673 MYOCARDIAL ISCHAEMIA 2 0.0002
674 INTERNATIONAL NORMALISED RATIO INCREASED 5 0.0002
675 MYOCARDITIS 2 0.0002
676 MUSCULOSKELETAL DISCOMFORT 3 0.0002
677 NEOPLASM 2 0.0002
678 MADAROSIS 2 0.0002
679 VASCULITIS 2 0.0002
680 DYSPHONIA 10 0.0002
681 BACTERAEMIA 2 0.0002
682 ABDOMINAL DISCOMFORT 28 0.0002
683 WRIST FRACTURE 2 0.0002
684 LACRIMATION INCREASED 5 0.0002
685 BLOOD PRESSURE INCREASED 25 0.0002
686 AGITATION 12 0.0002
687 MUSCLE SPASTICITY 2 0.0002
688 SMALL INTESTINAL OBSTRUCTION 2 0.0002
689 PYREXIA 56 0.0002
690 CONJUNCTIVITIS 3 0.0002
691 CHOLANGITIS 1 0.0002
692 HAIR COLOUR CHANGES 2 0.0002
693 HEPATIC CIRRHOSIS 3 0.0002
694 BLOOD SODIUM DECREASED 3 0.0002
695 HYPOCALCAEMIA 3 0.0002
696 RENAL FAILURE 21 0.0002
697 MUSCLE ATROPHY 2 0.0002
698 GASTRIC ULCER 3 0.0002
699 MUSCULOSKELETAL DISORDER 3 0.0002
700 INJECTION SITE IRRITATION 2 0.0002
701 EMOTIONAL DISTRESS 19 0.0002
702 ENTERITIS 1 0.0002
703 METASTASES TO CENTRAL NERVOUS SYSTEM 2 0.0002
704 PRESCRIBED OVERDOSE 3 0.0002
705 CARDIAC FLUTTER 1 0.0002
706 ANGINA UNSTABLE 1 0.0002
707 IMMUNE SYSTEM DISORDER 2 0.0002
708 STAPHYLOCOCCAL INFECTION 5 0.0002
709 BLOOD PRESSURE ABNORMAL 3 0.0002
710 SPINAL FRACTURE 3 0.0001
711 QUALITY OF LIFE DECREASED 2 0.0001
712 FEAR 4 0.0001
713 PAIN OF SKIN 4 0.0001
714 DYSPHAGIA 14 0.0001
715 PRODUCT QUALITY ISSUE 20 0.0001
716 DRUG TOXICITY 2 0.0001
717 GINGIVAL BLEEDING 2 0.0001
718 FEELING ABNORMAL 35 0.0001
719 MATERNAL EXPOSURE DURING PREGNANCY 13 0.0001
720 CORONARY ARTERY OCCLUSION 2 0.0001
721 CENTRAL NERVOUS SYSTEM LESION 2 0.0001
722 HYPOMAGNESAEMIA 2 0.0001
723 GASTROINTESTINAL HAEMORRHAGE 12 0.0001
724 MASS 2 0.0001
725 DISSEMINATED INTRAVASCULAR COAGULATION 2 0.0001
726 DUODENAL ULCER 1 0.0001
727 DEATH 122 0.0001
728 SEASONAL ALLERGY 2 0.0001
729 FLATULENCE 8 0.0001
730 GAIT DISTURBANCE 27 0.0001
731 LEUKOPENIA 7 0.0001
732 SUBDURAL HAEMATOMA 2 0.0001
733 ANGINA PECTORIS 4 0.0001
734 CELLULITIS 7 0.0001
735 ALTERED STATE OF CONSCIOUSNESS 3 0.0001
736 WRONG TECHNIQUE IN DRUG USAGE PROCESS 5 0.0001
737 BONE PAIN 8 0.0001
738 SKIN HAEMORRHAGE 2 0.0001
739 RENAL INJURY 4 0.0001
740 ATRIAL FIBRILLATION 13 0.0001
741 CHROMATURIA 3 0.0001
742 DYSARTHRIA 5 0.0001
743 INTESTINAL OBSTRUCTION 5 0.0001
744 UNEVALUABLE EVENT 10 0.0001
745 ECONOMIC PROBLEM 2 0.0001
746 COLITIS 5 0.0001
747 AORTIC ANEURYSM 1 0.0001
748 VERTIGO 8 0.0001
749 DRUG DISPENSING ERROR 2 0.0001
750 INSURANCE ISSUE 2 0.0001
751 MUSCULOSKELETAL CHEST PAIN 2 0.0001
752 LUNG INFECTION 2 0.0001
753 DEPRESSED LEVEL OF CONSCIOUSNESS 5 0.0001
754 BLOOD LACTATE DEHYDROGENASE INCREASED 2 0.0001
755 HYPOTHYROIDISM 4 0.0001
756 BLOOD DISORDER 1 0.0001
757 DYSKINESIA 5 0.0001
758 NEUTROPHIL COUNT DECREASED 5 0.0001
759 ABNORMAL FAECES 1 0.0001
760 METASTASES TO BONE 2 0.0001
761 PRODUCT SUBSTITUTION ISSUE 7 0.0001
762 DYSGEUSIA 9 0.0001
763 GENERALISED TONIC-CLONIC SEIZURE 2 0.0001
764 URINARY RETENTION 4 0.0001
765 PALPITATIONS 14 0.0001
766 DRUG USE DISORDER 1 0.0001
767 HEMIPARESIS 2 0.0001
768 HEADACHE 74 0.0001
769 CONFUSIONAL STATE 19 0.0001
770 ANURIA 1 0.0001
771 RASH GENERALISED 3 0.0001
772 NERVOUSNESS 6 0.0001
773 SPEECH DISORDER 6 0.0001
774 ACUTE RESPIRATORY DISTRESS SYNDROME 2 0.0001
775 HEAD DISCOMFORT 2 0.0001
776 PRODUCT DOSE OMISSION ISSUE 33 0.0001
777 CARDIAC FAILURE CONGESTIVE 9 0.0001
778 FOETAL EXPOSURE DURING PREGNANCY 9 0.0001
779 TOOTHACHE 2 0.0001
780 OSTEOMYELITIS 2 0.0001
781 BRAIN NEOPLASM 1 0.0001
782 DIVERTICULITIS 3 0.0001
783 PROCEDURAL PAIN 3 0.0001
784 ARTHROPATHY 6 0.0001
785 RENAL DISORDER 5 0.0001
786 COUGH 30 0.0001
787 DYSPNOEA EXERTIONAL 4 0.0001
788 MYALGIA 18 0.0001
789 RED BLOOD CELL COUNT DECREASED 3 0.0001
790 MALAISE 46 0.0001
791 RASH ERYTHEMATOUS 5 0.0001
792 BALANCE DISORDER 9 0.0001
793 ERUCTATION 2 0.0001
794 HYPOGLYCAEMIA 5 0.0001
795 EAR PAIN 2 0.0001
796 AUTOIMMUNE DISORDER 1 0.0001
797 HAEMORRHOIDS 2 0.0001
798 CHOKING 2 0.0001
799 ORAL HERPES 2 0.0001
800 SKIN FISSURES 2 0.0001
801 INJECTION SITE REACTION 7 0.0001
802 FATIGUE 79 0.0001
803 UPPER LIMB FRACTURE 2 0.0001
804 BLOOD POTASSIUM DECREASED 3 0.0001
805 APHASIA 3 0.0001
806 DRUG LEVEL DECREASED 1 0.0001
807 EPILEPSY 3 0.0001
808 DRUG ADMINISTRATION ERROR 3 0.0001
809 DRY SKIN 13 0.0001
810 INFLAMMATION 5 0.0001
811 PULMONARY HYPERTENSION 2 0.0001
812 DERMATITIS 2 0.0001
813 MUSCULOSKELETAL PAIN 5 0.0001
814 RENAL IMPAIRMENT 8 0.0001
815 KNEE ARTHROPLASTY 2 0.0001
816 MOUTH ULCERATION 2 0.0001
817 VISION BLURRED 13 0.0001
818 BREAST PAIN 1 0.0001
819 IMPAIRED WORK ABILITY 2 0.0001
820 RASH PRURITIC 5 0.0001
821 SEPTIC SHOCK 4 0.0001
822 MENTAL DISORDER 4 0.0001
823 DENTAL CARIES 1 0.0001
824 GAMMA-GLUTAMYLTRANSFERASE INCREASED 2 0.0001
825 VIRAL INFECTION 3 0.0001
826 DEHYDRATION 12 0.0001
827 NECK PAIN 5 0.0001
828 PANCYTOPENIA 5 0.0001
829 TYPE 2 DIABETES MELLITUS 3 0.0001
830 BLISTER 5 0.0001
831 THERAPY NON-RESPONDER 4 0.0001
832 PRODUCT AVAILABILITY ISSUE 2 0.0001
833 HAEMATURIA 3 0.0001
834 ELECTROLYTE IMBALANCE 1 0.0001
835 COVID-19 PNEUMONIA 1 0.0001
836 SYSTEMIC LUPUS ERYTHEMATOSUS 3 0.0001
837 ATAXIA 1 0.0001
838 COMA 4 0.0001
839 SKIN BURNING SENSATION 6 0.0001
840 BLOOD PRESSURE FLUCTUATION 2 0.0001
841 LOCALISED INFECTION 2 0.0001
842 C-REACTIVE PROTEIN INCREASED 3 0.0001
843 URINARY TRACT INFECTION 14 0.0001
844 CEREBRAL INFARCTION 2 0.0001
845 DECREASED APPETITE 19 0.0001
846 INJECTION SITE ERYTHEMA 10 0.0001
847 CYST 1 0.0001
848 BLOOD ALKALINE PHOSPHATASE INCREASED 2 0.0001
849 EPISTAXIS 6 0.0001
850 HOT FLUSH 6 0.0001
851 DERMATITIS ALLERGIC 1 0.0001
852 BRAIN OEDEMA 1 0.0001
853 HAEMATEMESIS 2 0.0001
854 HYPOPHAGIA 2 0.0001
855 FALL 26 0.0001
856 ADVERSE DRUG REACTION 7 0.0001
857 SEIZURE 9 0.0001
858 HAEMATOMA 2 0.0001
859 RESPIRATORY TRACT INFECTION 2 0.0001
860 HAEMORRHAGE 8 0.0001
861 DEAFNESS 2 0.0001
862 BEDRIDDEN 1 0.0001
863 OROPHARYNGEAL PAIN 7 0.0001
864 ADVERSE REACTION 1 0.0001
865 BLOOD BILIRUBIN INCREASED 2 0.0001
866 ACUTE HEPATIC FAILURE 1 0.0001
867 RHABDOMYOLYSIS 3 0.0001
868 ACUTE KIDNEY INJURY 11 0.0001
869 CARPAL TUNNEL SYNDROME 1 0.0001
870 INCORRECT DRUG ADMINISTRATION DURATION 2 0.0001
871 HERPES ZOSTER 4 0.0001
872 INFECTION 10 0.0001
873 DRUG INEFFECTIVE 91 0.0001
874 MYOCARDIAL INFARCTION 12 0.0001
875 CARDIOMYOPATHY 1 0.0001
876 BRONCHITIS 5 0.0001
877 COLON CANCER 1 0.0001
878 HEPATIC FAILURE 2 0.0001
879 BLOOD COUNT ABNORMAL 1 0.0001
880 ILL-DEFINED DISORDER 4 0.0001
881 NEPHROLITHIASIS 3 0.0001
882 TINNITUS 3 0.0001
883 INJECTION SITE RASH 2 0.0001
884 DEVICE RELATED INFECTION 1 0.0001
885 ANKLE FRACTURE 1 0.0001
886 CARDIAC DISORDER 6 0.0001
887 NERVOUS SYSTEM DISORDER 2 0.0001
888 ARTHRITIS 5 0.0001
889 OCULAR HYPERAEMIA 3 0.0001
890 PRODUCTIVE COUGH 3 0.0001
891 ABSCESS 1 0.0001
892 BACK DISORDER 1 0.0001
893 IMPAIRED HEALING 2 0.0001
894 OSTEONECROSIS 2 0.0001
895 FEBRILE NEUTROPENIA 4 0.0001
896 OVERDOSE 13 0.0001
897 EYE PRURITUS 2 0.0001
898 NEUTROPENIA 8 0.0001
899 MALIGNANT NEOPLASM PROGRESSION 6 0.0001
900 THERAPY CESSATION 3 0.0001
901 BLOOD GLUCOSE INCREASED 11 0.0001
902 GASTRIC DISORDER 2 0.0001
903 WEIGHT DECREASED 16 0.0001
904 EOSINOPHILIA 1 0.0001
905 LYMPHADENOPATHY 2 0.0001
906 DIABETES MELLITUS INADEQUATE CONTROL 1 0.0001
907 DRUG ERUPTION 1 0.0001
908 PLATELET COUNT DECREASED 6 0.0001
909 THERAPY INTERRUPTED 4 0.0001
910 HYPERGLYCAEMIA 2 0.0001
911 BONE DISORDER 1 0.0001
912 AGRANULOCYTOSIS 1 0.0001
913 WEIGHT INCREASED 12 0.0001
914 HALLUCINATION 4 0.0001
915 WHITE BLOOD CELL COUNT INCREASED 2 0.0001
916 ACUTE RESPIRATORY FAILURE 1 0.0001
917 DYSTONIA 1 0.0001
918 PLASMA CELL MYELOMA 2 0.0001
919 ACTIVITIES OF DAILY LIVING IMPAIRED 1 0.0001
920 CATARACT 3 0.0001
921 IRRITABILITY 3 0.0000
922 STOMATITIS 3 0.0000
923 BONE MARROW FAILURE 1 0.0000
924 BODY TEMPERATURE INCREASED 1 0.0000
925 ALANINE AMINOTRANSFERASE INCREASED 3 0.0000
926 DEPRESSION 11 0.0000
927 ROAD TRAFFIC ACCIDENT 2 0.0000
928 HYPOACUSIS 2 0.0000
929 RHINORRHOEA 3 0.0000
930 AMNESIA 3 0.0000
931 INTENTIONAL PRODUCT USE ISSUE 4 0.0000
932 INJECTION SITE PAIN 14 0.0000
933 APPLICATION SITE PAIN 1 0.0000
934 INJECTION SITE PRURITUS 3 0.0000
935 COLITIS ULCERATIVE 2 0.0000
936 APPLICATION SITE PRURITUS 1 0.0000
937 DEVICE MALFUNCTION 3 0.0000
938 DISEASE RECURRENCE 2 0.0000
939 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 2 0.0000
940 DIABETIC KETOACIDOSIS 1 0.0000
941 CEREBROVASCULAR ACCIDENT 7 0.0000
942 ENCEPHALOPATHY 1 0.0000
943 FLUID RETENTION 2 0.0000
944 HOSPITALISATION 6 0.0000
945 APPLICATION SITE ERYTHEMA 1 0.0000
946 DEPRESSED MOOD 2 0.0000
947 DRUG INTERACTION 6 0.0000
948 EAR INFECTION 1 0.0000
949 INSOMNIA 10 0.0000
950 TREATMENT NONCOMPLIANCE 2 0.0000
951 INFLUENZA LIKE ILLNESS 3 0.0000
952 DEMENTIA 1 0.0000
953 ALOPECIA 7 0.0000
954 BLOOD CREATINE PHOSPHOKINASE INCREASED 1 0.0000
955 PRODUCT STORAGE ERROR 3 0.0000
956 DISEASE PROGRESSION 4 0.0000
957 NASOPHARYNGITIS 6 0.0000
958 EMOTIONAL DISORDER 1 0.0000
959 VISUAL IMPAIRMENT 4 0.0000
960 MIGRAINE 3 0.0000
961 CYSTITIS 1 0.0000
962 DEVICE EXPULSION 2 0.0000
963 CHOLELITHIASIS 1 0.0000
964 DYSPEPSIA 3 0.0000
965 TOXICITY TO VARIOUS AGENTS 5 0.0000
966 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 1 0.0000
967 HEPATIC ENZYME INCREASED 2 0.0000
968 DELIRIUM 1 0.0000
969 COVID-19 5 0.0000
970 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 2 0.0000
971 CEREBRAL HAEMORRHAGE 1 0.0000
972 CRYING 1 0.0000
973 UNDERDOSE 2 0.0000
974 ACCIDENTAL OVERDOSE 1 0.0000
975 DYSURIA 1 0.0000
976 INCORRECT DOSE ADMINISTERED 6 0.0000
977 DEVICE BREAKAGE 1 0.0000
978 BLINDNESS 1 0.0000
979 DEVICE DISLOCATION 1 0.0000
980 ADVERSE EVENT 2 0.0000
981 PRODUCT USE ISSUE 4 0.0000
982 NEUROPATHY PERIPHERAL 2 0.0000
983 BLOOD GLUCOSE DECREASED 1 0.0000
984 CONTUSION 2 0.0000
985 AGGRESSION 1 0.0000
986 SINUSITIS 2 0.0000
987 ILLNESS 2 0.0000
988 WHITE BLOOD CELL COUNT DECREASED 2 0.0000
989 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
990 INFLUENZA 2 0.0000
991 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 3 0.0000
992 DRUG ABUSE 1 0.0000
993 DRUG WITHDRAWAL SYNDROME 1 0.0000
994 BREAST CANCER 1 0.0000
995 DRUG DOSE OMISSION 1 0.0000